MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Assets | ₹4,325 Cr | ₹4,404 Cr | ₹3,880 Cr | ₹2,820 Cr | ₹1,943 Cr |
What is the latest Total Current Assets ratio of MANKIND PHARMA ?
Year | Total Current Assets |
---|---|
Mar2023 | ₹4,325 Cr |
Mar2022 | ₹4,404 Cr |
Mar2021 | ₹3,880 Cr |
Mar2020 | ₹2,820 Cr |
Mar2019 | ₹1,943 Cr |
How is Total Current Assets of MANKIND PHARMA Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹4,325 Cr | -1.80 | |
Mar2022 | ₹4,404 Cr | 13.51 | |
Mar2021 | ₹3,880 Cr | 37.60 | |
Mar2020 | ₹2,820 Cr | 45.10 | |
Mar2019 | ₹1,943 Cr | - |
Compare Total Current Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹83,809.5 Cr | -6.5% | -7.6% | 57% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2% | -0.3% | 59.8% | Stock Analytics | |
CIPLA | ₹114,654.0 Cr | 6% | 2.8% | 50.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,348.0 Cr | 3.7% | 5.8% | 17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 2.6% | 7.9% | 94.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,429.4 Cr | -1.3% | -2.8% | 31.5% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.5% |
-7.6% |
57% |
SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses